Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Impact of a National Cancer Prevention and Treatment Program on the Prevalence of Late-Stage Breast Cancer Diagnoses in Oklahoma.

Janitz A, Wendelboe AM, Chou AF, Frank S, Watkins A, Thompson D, Campbell J.

J Okla State Med Assoc. 2016 Jul-Aug;109(7-8):366-373.

2.

Evaluation of health benefits and harms of the breast cancer screening programme in the Basque Country using discrete event simulation.

Arrospide A, Rue M, van Ravesteyn NT, Comas M, Larrañaga N, Sarriugarte G, Mar J.

BMC Cancer. 2015 Oct 12;15:671. doi: 10.1186/s12885-015-1700-4.

3.

An analysis of mass screening strategies using a mathematical model: comparison of breast cancer screening in Japan and the United States.

Tsunematsu M, Kakehashi M.

J Epidemiol. 2015;25(2):162-71. doi: 10.2188/jea.JE20140047. Epub 2014 Dec 6.

4.

An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain.

Arrospide A, Forné C, Rué M, Torà N, Mar J, Baré M.

BMC Cancer. 2013 Dec 10;13:587. doi: 10.1186/1471-2407-13-587.

5.

Multilevel intervention research: lessons learned and pathways forward.

Clauser SB, Taplin SH, Foster MK, Fagan P, Kaluzny AD.

J Natl Cancer Inst Monogr. 2012 May;2012(44):127-33. doi: 10.1093/jncimonographs/lgs019.

6.

Contribution of early detection and adjuvant treatments to breast cancer mortality reduction in Catalonia, Spain.

Vilaprinyo E, Puig T, Rue M.

PLoS One. 2012;7(1):e30157. doi: 10.1371/journal.pone.0030157. Epub 2012 Jan 17.

7.

Modeling the impact of population screening on breast cancer mortality in the United States.

Mandelblatt JS, Cronin KA, Berry DA, Chang Y, de Koning HJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, van Ravesteyn NT, Zelen M, Feuer EJ.

Breast. 2011 Oct;20 Suppl 3:S75-81. doi: 10.1016/S0960-9776(11)70299-5.

8.

Interpreting overdiagnosis estimates in population-based mammography screening.

de Gelder R, Heijnsdijk EA, van Ravesteyn NT, Fracheboud J, Draisma G, de Koning HJ.

Epidemiol Rev. 2011;33:111-21. doi: 10.1093/epirev/mxr009. Epub 2011 Jun 27. Review.

9.

Cost-effectiveness of early detection of breast cancer in Catalonia (Spain).

Carles M, Vilaprinyo E, Cots F, Gregori A, Pla R, Román R, Sala M, Macià F, Castells X, Rue M.

BMC Cancer. 2011 May 23;11:192. doi: 10.1186/1471-2407-11-192.

10.

Simulation models of obesity: a review of the literature and implications for research and policy.

Levy DT, Mabry PL, Wang YC, Gortmaker S, Huang TT, Marsh T, Moodie M, Swinburn B.

Obes Rev. 2011 May;12(5):378-94. doi: 10.1111/j.1467-789X.2010.00804.x. Epub 2010 Oct 26. Review.

11.

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network..

Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010. Erratum in: Ann Intern Med. 2010 Jan 19;152(2):136.

12.

Dissemination of periodic mammography and patterns of use, by birth cohort, in Catalonia (Spain).

Rue M, Carles M, Vilaprinyo E, Martinez-Alonso M, Espinas JA, Pla R, Brugulat P.

BMC Cancer. 2008 Nov 17;8:336. doi: 10.1186/1471-2407-8-336.

13.

Competing risks to breast cancer mortality in Catalonia.

Vilaprinyo E, Gispert R, Martínez-Alonso M, Carles M, Pla R, Espinàs JA, Rué M.

BMC Cancer. 2008 Nov 12;8:331. doi: 10.1186/1471-2407-8-331.

14.

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination.

Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA.

Popul Health Metr. 2007 Oct 29;5:11.

Supplemental Content

Support Center